Robust, Fully-automated Assessment of Cerebral Perivascular Spaces and White Matter Lesions: a Multicentre MRI Longitudinal Study of Their Evolution and Association with Risk of Dementia and Accelerated Brain Atrophy

Overview

Journal EBioMedicine

Specialty Biomedical Engineering

Date 2024 Dec 25

PMID 39721217

Authors

Giuseppe Barisano

Michael Iv

Jeiran Choupan

Melanie Hayden-Gephart

Affiliations

Soon will be listed here.

Abstract

Background: Perivascular spaces (PVS) on brain MRI are surrogates for small parenchymal blood vessels and their perivascular compartment, and may relate to brain health. However, it is unknown whether PVS can predict dementia risk and brain atrophy trajectories in participants without dementia, as longitudinal studies on PVS are scarce and current methods for PVS assessment lack robustness and inter-scanner reproducibility.

Methods: We developed a robust algorithm to automatically assess PVS count and size on clinical MRI, and investigated 1) their relationship with dementia risk and brain atrophy in participants without dementia, 2) their longitudinal evolution, and 3) their potential use as a screening tool in simulated clinical trials. We analysed 46,478 clinical measurements of cognitive functioning and 20,845 brain MRI scans from 10,004 participants (71.1 ± 9.7 years-old, 56.6% women) from three publicly available observational studies on ageing and dementia (the Alzheimer's Disease Neuroimaging Initiative, the National Alzheimer's Coordinating Centre database, and the Open Access Series of Imaging Studies). Clinical and MRI data collected between 2004 and 2022 were analysed with consistent methods, controlling for confounding factors, and combined using mixed-effects models.

Findings: Our fully-automated method for PVS assessment showed excellent inter-scanner reproducibility (intraclass correlation coefficients >0.8). Fewer PVS and larger PVS diameter at baseline predicted higher dementia risk and accelerated brain atrophy. Longitudinal trajectories of PVS markers differed significantly in participants without dementia who converted to dementia compared with non-converters. In simulated placebo-controlled trials for treatments targeting cognitive decline, screening out participants at low risk of dementia based on our PVS markers enhanced the power of the trial independently of Alzheimer's disease biomarkers.

Interpretation: These robust cerebrovascular markers predict dementia risk and brain atrophy and may improve risk-stratification of patients, potentially reducing cost and increasing throughput of clinical trials to combat dementia.

Funding: US National Institutes of Health.

References

Zhu Y, Dufouil C, Soumare A, Mazoyer B, Chabriat H, Tzourio C . High degree of dilated Virchow-Robin spaces on MRI is associated with increased risk of dementia. J Alzheimers Dis. 2010; 22(2):663-72. DOI: 10.3233/JAD-2010-100378. View

Iliff J, Wang M, Liao Y, Plogg B, Peng W, Gundersen G . A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med. 2012; 4(147):147ra111. PMC: 3551275. DOI: 10.1126/scitranslmed.3003748. View

Van Essen D, Smith S, Barch D, Behrens T, Yacoub E, Ugurbil K . The WU-Minn Human Connectome Project: an overview. Neuroimage. 2013; 80:62-79. PMC: 3724347. DOI: 10.1016/j.neuroimage.2013.05.041. View

Chappell M, Groves A, MacIntosh B, Donahue M, Jezzard P, Woolrich M . Partial volume correction of multiple inversion time arterial spin labeling MRI data. Magn Reson Med. 2011; 65(4):1173-83. DOI: 10.1002/mrm.22641. View

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984; 34(7):939-44. DOI: 10.1212/wnl.34.7.939. View

Hays C, Zlatar Z, Wierenga C . The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer's Disease. Cell Mol Neurobiol. 2016; 36(2):167-79. PMC: 5278904. DOI: 10.1007/s10571-015-0261-z. View

Piantino J, Boespflug E, Schwartz D, Luther M, Morales A, Lin A . Characterization of MR Imaging-Visible Perivascular Spaces in the White Matter of Healthy Adolescents at 3T. AJNR Am J Neuroradiol. 2020; 41(11):2139-2145. PMC: 7658833. DOI: 10.3174/ajnr.A6789. View

McKhann G, Knopman D, Chertkow H, Hyman B, Jack Jr C, Kawas C . The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7(3):263-9. PMC: 3312024. DOI: 10.1016/j.jalz.2011.03.005. View

Kress B, Iliff J, Xia M, Wang M, Wei H, Zeppenfeld D . Impairment of paravascular clearance pathways in the aging brain. Ann Neurol. 2014; 76(6):845-61. PMC: 4245362. DOI: 10.1002/ana.24271. View

10.

VanderWeele T . Principles of confounder selection. Eur J Epidemiol. 2019; 34(3):211-219. PMC: 6447501. DOI: 10.1007/s10654-019-00494-6. View

11.

Kim J, Nam Y, Kim S, Shin N, Kim H . MRI-visible Perivascular Spaces in the Neonatal Brain. Radiology. 2023; 307(2):e221314. DOI: 10.1148/radiol.221314. View

12.

Bookheimer S, Salat D, Terpstra M, Ances B, Barch D, Buckner R . The Lifespan Human Connectome Project in Aging: An overview. Neuroimage. 2018; 185:335-348. PMC: 6649668. DOI: 10.1016/j.neuroimage.2018.10.009. View

13.

Weiner M, Veitch D, Aisen P, Beckett L, Cairns N, Green R . The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement. Alzheimers Dement. 2016; 13(5):561-571. PMC: 5536850. DOI: 10.1016/j.jalz.2016.10.006. View

14.

Sepehrband F, Barisano G, Sheikh-Bahaei N, Choupan J, Cabeen R, Lynch K . Volumetric distribution of perivascular space in relation to mild cognitive impairment. Neurobiol Aging. 2021; 99:28-43. PMC: 7902350. DOI: 10.1016/j.neurobiolaging.2020.12.010. View

15.

Budelier M, Bateman R . Biomarkers of Alzheimer Disease. J Appl Lab Med. 2019; 5(1):194-208. PMC: 7246147. DOI: 10.1373/jalm.2019.030080. View

16.

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

17.

Fagan A, Shaw L, Xiong C, Vanderstichele H, Mintun M, Trojanowski J . Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology. Arch Neurol. 2011; 68(9):1137-44. PMC: 3154969. DOI: 10.1001/archneurol.2011.105. View

18.

Beach T, Wilson J, Sue L, Newell A, Poston M, Cisneros R . Circle of Willis atherosclerosis: association with Alzheimer's disease, neuritic plaques and neurofibrillary tangles. Acta Neuropathol. 2006; 113(1):13-21. DOI: 10.1007/s00401-006-0136-y. View

19.

Barisano G, Sepehrband F, Collins H, Jillings S, Jeurissen B, Taylor J . The effect of prolonged spaceflight on cerebrospinal fluid and perivascular spaces of astronauts and cosmonauts. Proc Natl Acad Sci U S A. 2022; 119(17):e2120439119. PMC: 9169932. DOI: 10.1073/pnas.2120439119. View

20.

Vernooij M, Pizzini F, Schmidt R, Smits M, Yousry T, Bargallo N . Dementia imaging in clinical practice: a European-wide survey of 193 centres and conclusions by the ESNR working group. Neuroradiology. 2019; 61(6):633-642. PMC: 6511357. DOI: 10.1007/s00234-019-02188-y. View